Le Lézard
Classified in: Business, Covid-19 virus
Subjects: LAW, ATY

Scott+Scott Attorneys at Law LLP Reminds Investors of Pending Securities Class Actions Against Vaxart, Inc. (VXRT) and October 23, 2020 Lead Plaintiff Deadline


NEW YORK, Oct. 1, 2020 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, reminds investors that class action lawsuits bringing federal securities claims are pending against Vaxart, Inc. (NASDAQ: VXRT) ("Vaxart" or the "Company"), certain directors and officers of the Company, and Armistice Capital LLP. The lead plaintiff deadline in these cases is October 23, 2020. 

If you purchased Vaxart stock between June 25, 2020 and July 25, 2020, and have over $100,000 in realized or unrealized losses, you are encouraged to contact a Scott+Scott attorney for additional information at (844) 818-6982 or [email protected]. 

Vaxart is a small, clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its proprietary oral vaccine platform.  In early 2020, Vaxart purportedly began to develop a Covid-19 vaccine.

In late June 2020, Vaxart made a couple of announcements regarding its Covid-19 vaccine and the stock price increased dramatically.

Soon after these announcements, Vaxart's largest shareholder, Armistice Capital LLP, sold massive amounts of its Vaxart shares for a huge profit.

Then, on July 25, 2020, The New York Times published an article entitled Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine.  The article clarified one of Vaxart's announcements and reported that, "Vaxart is not among the companies selected to receive significant financial support from [the U.S. Government's Operation] Warp Speed."

On this news, the price of Vaxart shares dropped and the Company's stock price has continued to decline.

What You Can Do

If you purchased Vaxart stock between June 25, 2020 and July 25, 2020 and have questions about this notice or your legal rights, you are encouraged to contact attorney Joe Pettigrew at (844) 818-6982 or [email protected]

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

CONTACT:

Joe Pettigrew
Scott+Scott Attorneys at Law LLP 
230 Park Avenue, 17th Floor, New York, NY 10169-1820
(844) 818-6982
[email protected]

SOURCE Scott+Scott Attorneys at Law LLP


These press releases may also interest you

at 18:50
In response to the unprecedented challenges that Latin America has faced during various health crises such as AH1N1, Zika, COVID-19, and Dengue, a prominent group of former health ministers and public health academics from the region has published in...

at 18:00
Simply Better Brands Corp. ("SBBC" or the "Company") announces that, further to the Company's news release dated January 25, 2023, and in connection with the Branding Earnout Agreement dated January 25, 2023, the Company has issued 89,966 common...

at 16:35
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Chegg, Inc. . Chegg is a publicly traded educational technology...

at 16:30
Today, the Biden-Harris Administration released a final rule under Section 1557, the core nondiscrimination provision of the Affordable Care Act. This groundbreaking rule marks a critical step in protecting access to health care and coverage for...

at 16:30
Farmmi, Inc. ("Farmmi" or the "Company") , an agriculture products supplier in China, today announced that on April 22, 2024, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in...

at 16:20
AMC Entertainment Holdings, Inc. (the "Company," or "AMC"), today released preliminary results for the first quarter ended March 31, 2024. The preliminary results are unaudited, subject to completion of the Company's financial reporting processes,...



News published on and distributed by: